Phytochemical and clinical effect of a herbal medicine containing mint, rosemary, lavender, and clove compared to placebo on the prevention and control of migraine symptoms

INTERVENTION: Intervention 1: Intervention group 1: Routine treatment plus herbal medicine containing mint applied as local massage on the temples, neck, forehead, and behind the ears three times per week for one month. Intervention 2: Intervention group 2: Routine treatment plus herbal medicine containing rosemary applied as local massage on the temples, neck, forehead, and behind the ears three times per week for one month. Intervention 3: Intervention group 3: Routine treatment plus herbal medicine containing lavender applied as local massage on the temples, neck, forehead, and behind the ears three times per week for one month. Intervention 4: Intervention group 4: Routine treatment plus combined herbal medicine containing clove applied as local massage on the temples, neck, forehead, and behind the ears three times per week for one month. Intervention 5: Control group: Routine treatment plus placebo without any herbal ingredient applied as local massage on the temples, neck, forehead, and behind the ears three times per week for one month. CONDITION: Migraine. ; Migraine PRIMARY OUTCOME: Headache severity. Timepoint: Before intervention and one month later. Method of measurement: Using the Visual Analogue Scale (VAS). Mean duration of migraine attacks. Timepoint: Before intervention and one month later. Method of measurement: By medical history. Number of migraine attacks. Timepoint: Before intervention and one month later. Method of measurement: By medical history. SECONDARY OUTCOME: Amount of analgesic medication use. Timepoint: before intervention and one month later. Method of measurement: By medical history. Improvement in sleep quality. Timepoint: Before intervention and one month later. Method of measurement: Using the Pittsburgh Sleep Quality Inde X(PSQI). Mean mood and anxiety score. Timepoint: before intervention and one month later. Method of measurement: Using the Depression Anxiety Stress Scales ‐ 21 (DASS‐21). Mean patient satisfaction score. Timepoint: Before intervention and one month later. Method of measurement: Using a researcher‐designed questionnaire. INCLUSION CRITERIA: Age 18 to 55 years, Diagnosis of migraine, Experience of at least 4 migraine attacks in the past three months,